Comment
Important considerations in LHRH antagonist therapy for prostate cancer
Affiliations
- PMID: 19626833
Item in Clipboard
Comment
Important considerations in LHRH antagonist therapy for prostate cancer
Oncology (Williston Park).
2009 Jun.
No abstract available
Comment on
-
The role of LHRH antagonists in the treatment of prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):626-30. Oncology (Williston Park). 2009. PMID: 19626830 Review.
Similar articles
-
LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?Oncology (Williston Park). 2009 Jun;23(7):631-2. Oncology (Williston Park). 2009. PMID: 19626831 No abstract available.
-
Is there a role for LHRH antagonists in prostate cancer?Oncology (Williston Park). 2009 Jun;23(7):632, 635. Oncology (Williston Park). 2009. PMID: 19626832 No abstract available.
-
The role of LHRH antagonists in the treatment of prostate cancer.Oncology (Williston Park). 2009 Jun;23(7):626-30. Oncology (Williston Park). 2009. PMID: 19626830 Review.
-
Pharmacotherapy for prostate cancer: the role of hormonal treatment.Discov Med. 2007 Aug;7(39):118-24. Discov Med. 2007. PMID: 18093474
-
[Recent advance in luteinizing hormone-releasing hormone analogue therapy in management of prostate cancer].Nihon Rinsho. 1998 Aug;56(8):2108-13. Nihon Rinsho. 1998. PMID: 9750517 Review. Japanese.
Cited by
-
Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers.Res Rep Urol. 2022 Mar 30;14:87-108. doi: 10.2147/RRU.S303215. eCollection 2022. Res Rep Urol. 2022. PMID: 35386270 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical